Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

[1]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[2]  Z. Mahfoud,et al.  Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. , 2008, The Journal of clinical endocrinology and metabolism.

[3]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[4]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[5]  P. Raggi,et al.  Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R. Tilvis,et al.  Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. , 2008, European journal of endocrinology.

[7]  S. Booth,et al.  Vitamin D3 in fat tissue , 2008, Endocrine.

[8]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[9]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[10]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  K. Kalantar-Zadeh,et al.  Association of activated vitamin D treatment and mortality in chronic kidney disease. , 2008, Archives of internal medicine.

[12]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[13]  Graeme Jones,et al.  Cardiovascular risks of calcium supplements in women , 2008, BMJ : British Medical Journal.

[14]  P. Barber,et al.  Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial , 2008, BMJ : British Medical Journal.

[15]  B. Mitchell,et al.  Decreased Bone Mineral Density Is Correlated with Increased Subclinical Atherosclerosis in Older, but not Younger, Mexican American Women and Men: The San Antonio Family Osteoporosis Study , 2007, Calcified Tissue International.

[16]  N. Singh,et al.  Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.

[17]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[18]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.

[19]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[20]  M. Holick,et al.  Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.

[21]  R. Simpson,et al.  Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  Grace H. Lee,et al.  Impact of kidney bone disease and its management on survival of patients on dialysis. , 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[23]  A. Shao,et al.  Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.

[24]  Stylianos N. Zerefos,et al.  Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis , 2007, International Urology and Nephrology.

[25]  A. Zittermann.  Vitamin D and disease prevention with special reference to cardiovascular disease. , 2006, Progress in biophysics and molecular biology.

[26]  P. Lips.  Vitamin D physiology. , 2006, Progress in biophysics and molecular biology.

[27]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[28]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[29]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[30]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[31]  F. Pattou,et al.  1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor , 2006, Apoptosis.

[32]  E. Warburton,et al.  Reduced Vitamin D in Acute Stroke , 2006, Stroke.

[33]  G. Targher,et al.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. , 2006, Diabetes care.

[34]  H. Vestergaard,et al.  Increased plasma N‐terminal pro‐B‐type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism , 2005, Clinical endocrinology.

[35]  P. Raggi,et al.  Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  B. Boucher,et al.  Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. , 2004, The American journal of clinical nutrition.

[37]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[38]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[39]  B. Hollis,et al.  Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[40]  E. Rydberg,et al.  Primary hyperparathyroidism and heart disease--a review. , 2004, European heart journal.

[41]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[42]  Bess Dawson-Hughes,et al.  Effect of Vitamin D on falls: a meta-analysis. , 2004, JAMA.

[43]  M. Holick,et al.  Vitamin D intake in the United States. , 2003, Journal of the American Dietetic Association.

[44]  M. Daudon,et al.  Drug-induced renal calculi: epidemiology, prevention and management. , 2004, Drugs.

[45]  G. Plotnikoff,et al.  Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. , 2003, Mayo Clinic proceedings.

[46]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[47]  P. Vestergaard,et al.  Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism , 2003, BMJ : British Medical Journal.

[48]  Yan Chun Li.  Vitamin D regulation of the renin–angiotensin system , 2003, Journal of cellular biochemistry.

[49]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[50]  M. Holick,et al.  Vitamin D insufficiency among free-living healthy young adults. , 2002, The American journal of medicine.

[51]  B. Dawson-Hughes,et al.  Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.

[52]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[53]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[54]  T. Chen,et al.  Vitamin D intoxication associated with an over-the-counter supplement. , 2001, The New England journal of medicine.

[55]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[56]  H. Glerup,et al.  Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.

[57]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[58]  Arya M. Sharma,et al.  Ultraviolet B and blood pressure , 1998, The Lancet.

[59]  C. Bell,et al.  Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1998, Hypertension.

[60]  K. Watson,et al.  Active serum vitamin D levels are inversely correlated with coronary calcification. , 1997, Circulation.

[61]  R. Morris,et al.  1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. , 1991, The Journal of clinical investigation.

[62]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[63]  M. Holick,et al.  Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.

[64]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[65]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[66]  H. Ives,et al.  1 , 25-Dihydroxyvitamin D 3 Modulates Growth of Vascular Smooth Muscle Cells , 2022 .